News UK launches review of clinical trials amid worrying decline Review comes after drug industry saw a 41% decline in new trial starts between 2017 and 2021.
Sales & Marketing Automating - and optimising - HCP engagement to maximise com... Life sciences marketing has rapidly evolved to mirror that of consumer retail.
R&D How Design of Experiments enriches life sciences’ findings Design of Experiments (DOE) is a methodology misunderstood by many, understood by some, and actively used by even fewer than that.
Digital The importance of AI literacy in life sciences The promise and value of artificial intelligence (AI) in life sciences are somewhat obscured by the over-generalisation of this technology.
R&D Connected customer data: a golden opportunity for pharma mar... Data is transforming life sciences, but many organisations are not using its full potential.
Sales & Marketing Another inside peek into pharma marketing at PM Society lear... The PM Society’s ‘Is Pharma Marketing built on Straw, Sticks, or Bricks?’ interactive information afternoon, held at The Royal Society of Medicine in London late last year, set out to bring
News NICE backs AZ/Ionis' Wainzua for ATTR polyneuropathy AstraZeneca and Ionis' Wainzua has been recommended for NHS use in the treatment of patients with ATTR polyneuropathy
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
